Thinnr Protocol Liquid
NDC Package 85095-100-04
Package Information
Thinnr Protocol (adeps suillus, adrenalinium, adrenocorticotrophin, agrimonia eupatoria flos, ammounium bromatum, anacardium orientale, antimonium crudum, castanea sativa flos, calcarea carbonica, coenzyme a, cortisone aceticum, fucus vesiculosus, hypothalamus, kali bichromicum, pituitarum posterium, rna, sabadilla, staphysagria, thyroidinum) liquids is shake well before us. This formulation utilizes a liquid delivery system. Marketed by Slimcell, Llc, this product is identified by NDC 85095-100.
Identification & Billing
Clinical Specifications
- ADEPS SUILLUS 8 [hp_X]/mL
- AGRIMONIA EUPATORIA FLOWER 8 [hp_X]/mL
- AMMONIUM BROMIDE 8 [hp_X]/mL
- ANTIMONY TRISULFIDE 8 [hp_X]/mL
- BOS TAURUS HYPOTHALAMUS 8 [hp_X]/mL
- CASTANEA SATIVA FLOWER 8 [hp_X]/mL
- COENZYME A 8 [hp_X]/mL
- CORTICOTROPIN 8 [hp_X]/mL
- CORTISONE ACETATE 8 [hp_X]/mL
- DELPHINIUM STAPHISAGRIA SEED 8 [hp_X]/mL
- EPINEPHRINE 8 [hp_X]/mL
- FUCUS VESICULOSUS 8 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 8 [hp_X]/mL
- POTASSIUM DICHROMATE 8 [hp_X]/mL
- SACCHAROMYCES CEREVISIAE RNA 8 [hp_X]/mL
- SCHOENOCAULON OFFICINALE SEED 8 [hp_X]/mL
- SEMECARPUS ANACARDIUM JUICE 8 [hp_X]/mL
- SUS SCROFA PITUITARY GLAND, POSTERIOR 8 [hp_X]/mL
- THYROID, UNSPECIFIED 8 [hp_X]/mL
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Adrenocorticotropic Hormone - [CS]
- Adrenocorticotropic Hormone - [EPC] (Established Pharmacologic Class)
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
- Corticosteroid - [EPC] (Established Pharmacologic Class)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 85095 - Slimcell, Llc
- 85095-100 - Thinnr Protocol
- 85095-100-04 - 118 mL in 1 BOTTLE
- 85095-100 - Thinnr Protocol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85095-100-04 identifies a specific commercial package of 118 ml in 1 bottle of Thinnr Protocol, a human over the counter drug labeled by Slimcell, Llc. This liquid is formulated for oral use and contains adeps suillus; agrimonia eupatoria flower; ammonium bromide; antimony trisulfide; bos taurus hypothalamus; castanea sativa flower; coenzyme a; corticotropin; cortisone acetate; delphinium staphisagria seed; epinephrine; fucus vesiculosus; oyster shell calcium carbonate, crude; potassium dichromate; saccharomyces cerevisiae rna; schoenocaulon officinale seed; semecarpus anacardium juice; sus scrofa pituitary gland, posterior; thyroid, unspecified as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Slimcell, Llc on January 16, 2025. The current certification is valid through December 31, 2026.
How is this Slimcell, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85095010004. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.